Related Experiment Videos
[Pneumocystis carinii pneumonia]
F Gabriel Botella1, J V Balaguer Martínez, M Labios Gómez
1Servicio de Medicina Interna, Hospital Clínico Universitario, Valencia.
Insights
This study details twelve HIV-1 positive patients with Pneumocystis Carinii Pneumonia (PCP) diagnosed via bronchoalveolar lavage or induced sputum. Early diagnosis and new treatments are crucial given the disease
Area of Science:
- Infectious Diseases
- Immunology
- Pulmonology
Context:
- Presents twelve cases of Pneumocystis Carinii Pneumonia (PCP) hospitalized between 1989-1990.
- All patients were HIV-1 positive, aged 25-32, with low CD4 counts (<25% or 200 cells/mm³), and positive p24 antigen.
- Patient demographics included ten parenteral drug users and two homosexual men.
Purpose:
- To report on the clinical characteristics and diagnosis of PCP in a specific cohort.
- To highlight diagnostic methods including fibrobronchoscopy with bronchoaspiration/lavage and induced sputum.
- To emphasize the need for early diagnosis and treatment strategies for PCP.
Summary:
- Diagnosis was confirmed using toluidine blue O staining of samples obtained via fibrobronchoscopy (bronchoaspiration/bronchoalveolar lavage) or induced sputum.
- The study underscores the importance of diagnostic techniques for identifying PCP in immunocompromised individuals.
- Findings were based on a small cohort, providing insights into PCP presentation in the early HIV/AIDS epidemic.
Impact:
- Predicts a potential increase in PCP cases and a shift in affected demographics, including the elderly.
- Stresses the importance of developing new early diagnostic techniques for PCP.
- Highlights the potential emergence of novel treatments, including corticotherapy, for PCP management.
Abstract:
We present twelve cases of Pneumocystis Carinii Pneumonia (PCP) hospitalized at the Internal Medicine Service of the Hospital Clínico de Valencia between 1989 and 1990. All patients were infected by HIV-1, with ages between 25 and 32 years, with circulating CD4 lymphocytes lower than 25% or 200 cells per cubic millimeter and with positive p24 antigen. Ten of them were parenterally drug addicts and two of them, homosexuals. Diagnosis was made by fibrobronchoscopy (FB) with bronchoaspiration (BAS) and bronchoalveolar lavage (BAL), or sputum induced by physiological serum aerosol at three per cent, using in both cases blue tinction with toluidine 0 of the samples obtained. Given the foreseeable increase of this disease in our country, we stress the risk of a potential change in its clinical spectrum, affecting new population groups, mainly the elderly, as well as the development of new early diagnosis techniques and the emergence of new treatments, including corticotherapy.